Drug information for METOPIRONE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 250MG Prescription  (Reference Drug) METYRAPONE Metyrapone NOVARTIS 12911
2010-11-08 Letter
2010-11-04 Label
2004-05-07 Letter
TABLET; ORAL 250MG Discontinued   METYRAPONE Metyrapone NOVARTIS   "

Drug Adverse Effects information for METOPIRONE

Role code Indications Reaction # Reports
PS CUSHING'S SYNDROME ALANINE AMINOTRANSFERASE INCREASED 1
PS CUSHING'S SYNDROME ASPARTATE AMINOTRANSFERASE INCREASED 1
PS CUSHING'S SYNDROME GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
PS CUSHING'S SYNDROME LIVER FUNCTION TEST ABNORMAL 2
SS CUSHING'S SYNDROME ALANINE AMINOTRANSFERASE INCREASED 3
SS CUSHING'S SYNDROME ASPARTATE AMINOTRANSFERASE INCREASED 3
SS CUSHING'S SYNDROME GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
SS CUSHING'S SYNDROME LIVER FUNCTION TEST ABNORMAL 4
C MULTIPLE MYELOMA MITRAL VALVE INCOMPETENCE 1
Ads by Google